Company

KYNTRA BIO, INC.

KYNB · CIK 0000921299

SEC FORM 4

$1,786.95

Disposition (code F) of 209 shares at $8.55 per share.

Reporting Person Wettig Thane · Officer Title CEO · Transaction Code F

Traded Sep 6, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001815638-26-000011 · filed 2026-09-09 · View filing →

SEC FORM 4

$188.10

Disposition (code F) of 22 shares at $8.55 per share.

Reporting Person DeLucia David · Officer Title Chief Financial Officer · Transaction Code F

Traded Sep 6, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0002040705-26-000007 · filed 2026-09-09 · View filing →